Related Interviews

Data Readouts from CRISPR Trials Will Be Critical in 2019
April 11, 2019
Samy, Manisha

Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola

A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019
Prasad, Raju

Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit

Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola

Medical Diagnostics & Life Sciences - Zarak Khurshid - Caris & Company, Inc.
September 14, 2009

INVESTING IN DIABETES-RELATED STOCKS - DAVID A. KLIFF - DIABETIC INVESTOR
November 17, 2008

Joseph Galli - Haemacure Corporation (hae:tsx)
April 16, 2007

SOFTWARE COMPANIES & SECURITY PRODUCTS - WALTER PRITCHARD - COWEN & COMPANY, LLC
December 11, 2006

ALTERNATIVE ENERGY & COAL: ELIZABETH COLLINS - MORNINGSTAR INC
August 07, 2006

ROUNDTABLE FORUM: GAMING
July 10, 2006

David Wenner - B&g Foods Inc (bgf)
February 27, 2006

Alexander Dexne - Medigene Ag (mdgef)
October 26, 2004

Fredric Price - Biomarin Pharmaceutical Inc (bmrn)
May 03, 2004

OUTLOOK FOR BIOTECHNOLOGY: RENI BENJAMIN - RODMAN & RENSHAW
May 03, 2004

S.belgrad / L.starr - Janus Capital Group (jns)
June 23, 2003

Paul Averback - Nymox Pharmaceutical Corporation (nymx)
July 08, 2002

Stephen Sherwin - Cell Genesys Inc (cege)
June 02, 2002

Mark Chandler - Luminex Corporation (lmnx)
October 12, 2001

Stuart Collinson - Aurora Biosciences Corporation (absc)
May 07, 2001

Outlook For Managed Care Stocks: David Shove - Prudential Securities
April 02, 2001

High-yield Securities In Media: Bruce Cheen - First Union Securities
October 09, 2000